News | March 02, 2024
Cipla incorporates JV company in USA
Cipla completes transfer of Generics Business Undertaking
Cipla completes transfer of Generics Business Undertaking
The objective of GCMC is well aligned to WHO’s call to action and India’s National Biotechnology Development Strategy
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
First published clinical trial using live biotherapeutic candidate in Covid-19 patients suggests role in improving outcomes
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
The companies will spread the adoption of the latest HOS and Mass Spec technologies to help scientists improve the safety, stability, and effectiveness of biotherapeutics
Approval to dramatically change CAR-T therapies landscape
Acquisition will further strengthen Lonza’s bioconjugates offering through the integration of the industry-leading proprietary Synaffix technology platform and R&D capabilities, including payload and site-specific linker technology
Merck and Ridgeback will appeal the decision and request a re-examination of the CHMP’s opinion.
Thermo Fisher and Celltrio bring first-in-kind automation platform to address critical scale-up challenges in biotherapeutics RoboCell cell line automation platform
Subscribe To Our Newsletter & Stay Updated
